Source: European Medicines Agency (EU) Revision Year: 2026 Publisher: SFL Pharmaceuticals Deutschland GmbH, Marie-Curie-Strasse 8, 79539 Loerrach, Germany
Aumseqa 55 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Light yellow, 7 mm, round immediate release tablet debossed with "E1" on one side and plain on the reverse. |
Each film-coated tablet contains aumolertinib mesilate equivalent to 55 mg aumolertinib.
Excipients with known effect:
Each film-coated tablet contains 15.3 mg of lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
|
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose (E460) Film-coating: Polyvinyl alcohol (E1203) |
White, high density polyethylene (HDPE) bottle with an aluminium heat-induction sealed child-resistant closure, a silica gel desiccant cannister inside, and a white polypropylene (PP) cap.
Each bottle contains 60 film-coated tablets.
Each carton contains one bottle.
SFL Pharmaceuticals Deutschland GmbH, Marie-Curie-Strasse 8, 79539 Loerrach, Germany
EU/1/25/2006/001
| Drug | Countries | |
|---|---|---|
| AUMSEQA | Lithuania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.